The Baltimore Buprenorphine Initiative: A Comparison of Treatment Modalities for Addressing Heroin Addiction in an Urban-Based Community

2.50
Hdl Handle:
http://hdl.handle.net/10755/304482
Category:
Full-text
Type:
Presentation
Title:
The Baltimore Buprenorphine Initiative: A Comparison of Treatment Modalities for Addressing Heroin Addiction in an Urban-Based Community
Author(s):
Murphy, Lyn Stankiewicz; Oros, Marla T.
Lead Author STTI Affiliation:
Pi
Author Details:
Lyn Stankiewicz Murphy, PhD, MBA, MS, RN, lmurphy@son.umaryland.edu; Marla T. Oros, MS, RN;
Abstract:

Session presented on: Friday, July 26, 2013

Purpose: Adequate drug treatment for substance users continues to be a challenge for most United States (US) cities. In order to address heroin addiction in Baltimore, the Baltimore Buprenorphine Initiative (BBI) was implemented as a joint project to promote individualized, patient-centered buprenorphine therapy in conjunction with behavioral treatment to accelerate recovery from opioid addiction.'

Methods: The BBI sample consisted of 1,039 subjects treated with buprenorphine and counseling between January 1, 2008 and June 1, 2009. Demographic and outcome variables were evaluated against two comparison groups of 8,692 patients receiving methadone treatment and 6,664 patients receiving intensive outpatient or standard outpatient (IOP-OP) treatment.'Analytical methods were utilized to assess each of the three treatment groups in order to measure the simultaneous impact of a set of variables on an individual's LOS.

Results: The BBI sample consisted of 1,039 subjects treated between January 1, 2008 and June 1, 2009. Using analysis of variance, statistically significant differences among the groups were identified in three areas: age, lapse of time until admission to treatment, and length of stay in treatment. Controlling for age, gender, education, race, income, and employment, the following independent variables were used to predict LOS: lapse of time to admission, ASI scores, number of addictions, frequency of addictions, and group membership (BBI, methadone, or IOP).' Demographic characteristics accounted for 15.8 % of the variance (R2 = 0.158) with the overall model explaining 42.6% of the variance surrounding the dependent variable LOS (R2=0.426). The model was statistically significant (F=223.51, df 18, 5413, p<0.001).

Conclusion: The findings of this study have practical implications for the design and implementation of heroin addiction programs. The research indicates that focusing on these specific predictive variables early in the program design phase could increase recovery success rates as measured by length of stay.

Keywords:
heroin; drug addiction; buprenorphine
Repository Posting Date:
22-Oct-2013
Date of Publication:
22-Oct-2013 ; 22-Oct-2013
Conference Date:
2013
Conference Name:
24th International Nursing Research Congress
Conference Host:
Sigma Theta Tau International, the Honor Society of Nursing
Conference Location:
Prague, Czech Republic
Description:
24th International Nursing Research Congress Theme: Bridge the Gap Between Research and Practice Through Collaboration. Held at the Hilton Prague Hotel.

Full metadata record

DC FieldValue Language
dc.language.isoen_USen_GB
dc.language.isoenen
dc.type.categoryFull-texten
dc.typePresentationen
dc.titleThe Baltimore Buprenorphine Initiative: A Comparison of Treatment Modalities for Addressing Heroin Addiction in an Urban-Based Communityen
dc.contributor.authorMurphy, Lyn Stankiewiczen
dc.contributor.authorOros, Marla T.en
dc.contributor.departmentPien
dc.author.detailsLyn Stankiewicz Murphy, PhD, MBA, MS, RN, lmurphy@son.umaryland.edu; Marla T. Oros, MS, RN;en
dc.identifier.urihttp://hdl.handle.net/10755/304482-
dc.description.abstract<p>Session presented on: Friday, July 26, 2013</p><strong><b>Purpose</strong>: </b>Adequate drug treatment for substance users continues to be a challenge for most United States (US) cities. In order to address heroin addiction in Baltimore, the Baltimore Buprenorphine Initiative (BBI) was implemented as a joint project to promote individualized, patient-centered buprenorphine therapy in conjunction with behavioral treatment to accelerate recovery from opioid addiction.' <p><strong><b>Methods</strong>: </b>The BBI sample consisted of 1,039 subjects treated with buprenorphine and counseling between January 1, 2008 and June 1, 2009. Demographic and outcome variables were evaluated against two comparison groups of 8,692 patients receiving methadone treatment and 6,664 patients receiving intensive outpatient or standard outpatient (IOP-OP) treatment.'Analytical methods were utilized to assess each of the three treatment groups in order to measure the simultaneous impact of a set of variables on an individual's LOS. <p><strong><b>Results</strong>: </b>The BBI sample consisted of 1,039 subjects treated between January 1, 2008 and June 1, 2009. Using analysis of variance, statistically significant differences among the groups were identified in three areas: age, lapse of time until admission to treatment, and length of stay in treatment. Controlling for age, gender, education, race, income, and employment, the following independent variables were used to predict LOS: lapse of time to admission, ASI scores, number of addictions, frequency of addictions, and group membership (BBI, methadone, or IOP).' Demographic characteristics accounted for 15.8 % of the variance (R<sup>2 </sup>= 0.158) with the overall model explaining 42.6% of the variance surrounding the dependent variable LOS (R<sup>2</sup>=0.426). The model was statistically significant (F=223.51, df 18, 5413, p<0.001). <p><b><b>Conclusion: </b></b> The findings of this study have practical implications for the design and implementation of heroin addiction programs. The research indicates that focusing on these specific predictive variables early in the program design phase could increase recovery success rates as measured by length of stay.en
dc.subjectheroinen
dc.subjectdrug addictionen
dc.subjectbuprenorphineen
dc.date.available2013-10-22T20:36:53Z-
dc.date.issued2013-10-22-
dc.date.issued2013-10-22en
dc.date.accessioned2013-10-22T20:36:53Z-
dc.conference.date2013en
dc.conference.name24th International Nursing Research Congressen
dc.conference.hostSigma Theta Tau International, the Honor Society of Nursingen
dc.conference.locationPrague, Czech Republicen
dc.description24th International Nursing Research Congress Theme: Bridge the Gap Between Research and Practice Through Collaboration. Held at the Hilton Prague Hotel.en
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.